- Home
- MRNA vs APTV Comparison
MRNA vs APTV Comparison
Compare MRNA & APTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- APTV
- Stock Information
- Founded
- MRNA 2010
- APTV 2011
- Country
- MRNA United States
- APTV Switzerland
- Employees
- MRNA N/A
- APTV N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- APTV Auto Parts:O.E.M.
- Sector
- MRNA Health Care
- APTV Consumer Discretionary
- Exchange
- MRNA Nasdaq
- APTV Nasdaq
- Market Cap
- MRNA 10.6B
- APTV 11.5B
- IPO Year
- MRNA 2018
- APTV 1999
- Fundamental
- Price
- MRNA $24.25
- APTV $61.99
- Analyst Decision
- MRNA Hold
- APTV Buy
- Analyst Count
- MRNA 20
- APTV 19
- Target Price
- MRNA $51.94
- APTV $80.00
- AVG Volume (30 Days)
- MRNA 8.5M
- APTV 2.6M
- Earning Date
- MRNA 05-01-2025
- APTV 05-01-2025
- Dividend Yield
- MRNA N/A
- APTV N/A
- EPS Growth
- MRNA N/A
- APTV N/A
- EPS
- MRNA N/A
- APTV 6.35
- Revenue
- MRNA $3,177,000,000.00
- APTV $19,637,000,000.00
- Revenue This Year
- MRNA N/A
- APTV $2.91
- Revenue Next Year
- MRNA $11.16
- APTV $5.16
- P/E Ratio
- MRNA N/A
- APTV $9.76
- Revenue Growth
- MRNA N/A
- APTV N/A
- 52 Week Low
- MRNA $23.15
- APTV $47.19
- 52 Week High
- MRNA $170.47
- APTV $85.35
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- APTV 64.87
- Support Level
- MRNA $23.70
- APTV $58.18
- Resistance Level
- MRNA $28.52
- APTV $59.62
- Average True Range (ATR)
- MRNA 1.36
- APTV 1.71
- MACD
- MRNA -0.09
- APTV 1.06
- Stochastic Oscillator
- MRNA 11.11
- APTV 95.15
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About APTV Aptiv PLC
Aptiv PLC signal and power solutions segment supplies components and systems that make up a vehicle's electrical system, including wiring assemblies and harnesses, connectors, electrical centers, and hybrid electrical systems. The operating segments are grouped on the basis of similar product, market and operating factors: Signal and Power Solutions, which includes complete electrical architecture and component products. advanced Safety and User Experience, which includes vehicle technology and services in advanced safety, user experience, and smart vehicle computing and software, as well as cloud-native software platforms, autonomous driving technologies, and DevOps tools. Eliminations and Other.